Status:
UNKNOWN
Levels of Von Willebrand Factor Multimers and VWF-Cleaving Protease (ADAMTS-13) in Preterm and Neonate
Lead Sponsor:
Sheba Medical Center
Conditions:
Von Willebramd Factor
Eligibility:
All Genders
24-42 years
Brief Summary
Von Willebramd Factor (VWF) is an adhesive glycoprotein synthesized by megakaryocytes and endothelial cells.VWF has a central role in primary hemostasis and is a critical ligand for platelets adhesion...
Eligibility Criteria
Inclusion
- All infants born n our hospital between August 2007 and August 2009 will enter
Exclusion
- Thrombocytopenia, maternal aspirin
Key Trial Info
Start Date :
August 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2009
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00701610
Start Date
August 1 2007
End Date
August 1 2009
Last Update
June 19 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sheba-Medical-Center
Ramat Gan, Israel, 52621